Last reviewed · How we verify

Biological: mRNA-1273 — Competitive Intelligence Brief

Biological: mRNA-1273 (Biological: mRNA-1273) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: mRNA vaccine. Area: Infectious Disease.

phase 2 mRNA vaccine SARS-CoV-2 spike protein Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Biological: mRNA-1273 (Biological: mRNA-1273) — ModernaTX, Inc.. mRNA-based vaccine that encodes for the SARS-CoV-2 spike protein

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Biological: mRNA-1273 TARGET Biological: mRNA-1273 ModernaTX, Inc. phase 2 mRNA vaccine SARS-CoV-2 spike protein
batch 1 of Ad5-nCoV batch 1 of Ad5-nCoV Jiangsu Province Centers for Disease Control and Prevention marketed viral vector vaccine SARS-CoV-2 spike protein
Influenza Influenza and COVID-19 Combination A BioNTech marketed Non-Standardized Plant Allergenic Extract [EPC] SARS-CoV-2 spike protein and influenza hemagglutinin protein
Tozinameran 6 months to 4 years of age tozinameran-6-months-to-4-years-of-age Pfizer marketed vaccine SARS-CoV-2 spike protein
Tozinameran 12 Years of age and older tozinameran-12-years-of-age-and-older Pfizer marketed vaccine SARS-CoV-2 spike protein
MVC-COV1901(3 Months) MVC-COV1901(3 Months) Taoyuan General Hospital marketed Protein subunit vaccine SARS-CoV-2 spike protein
Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose variant-adapted-bnt162b2-omicron-xbb-1-5-10-microgram-dose Pfizer marketed mRNA vaccine SARS-CoV-2 spike protein

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (mRNA vaccine class)

  1. Pfizer · 12 drugs in this class
  2. ModernaTX, Inc. · 11 drugs in this class
  3. BioNTech SE · 5 drugs in this class
  4. Jules Bordet Institute · 5 drugs in this class
  5. Tan Tock Seng Hospital · 2 drugs in this class
  6. Clover Biopharmaceuticals AUS Pty · 1 drug in this class
  7. CanSino Biologics Inc. · 1 drug in this class
  8. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
  9. CSPC Megalith Biopharmaceutical Co.,Ltd. · 1 drug in this class
  10. Jens D Lundgren, MD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Biological: mRNA-1273 — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-mrna-1273. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: